馃 Informaci贸n sobre el COVID-19
Institucional
Institucional
Misi贸n y Visi贸n de ALAT
Estatutos y reglamentos
Comit茅 Ejecutivo
Fundaci贸n Inspira
Comunicaci贸n ALAT
Actividades de ALAT
Sociedades Nacionales
FIRS
FOLASOR
Certificados
Departamentos
Asma
Circulaci贸n pulmonar
Cirug铆a tor谩cica
Cuidado Respiratorio
Endoscopia respiratoria y neumolog铆a intervencionista
Enfermedades infecciosas
Enfermedades intersticiales
EPOC
Fisiopatolog铆a
Im谩genes
Medicina cr铆tica
Oncolog铆a tor谩cica
Pediatr铆a
Sue帽o
Tabaquismo
Trasplante Pulmonar
Tuberculosis
Cursos ALAT
Congresos
Congreso 2020
Congreso 2021
Recursos
COVID-19
Educativos
Publicaciones
Biblioteca
Neumoteca
Nuevo
Gu铆as ALAT
Becas y Cursos
MECOR
Becas
Estudios
PLATINO
Actualizaci贸n
Eventos
Contacto
Registrarme
Ingresar
Biblioteca
Inicio
Categor铆as
Temas
Convalescent Plasma to Treat COVID-19
Tratamientos
Tema
COVID-19
Recent discovery and development of inhibitors targeting coronaviruses
Tratamientos
Tema
COVID-19
Drug treatment options for the 2019-new coronavirus (2019- nCoV)
Tratamientos
Tema
COVID-19
Effective Treatment of Severe COVID-19 Patients with Tocilizumab
Tratamientos
Tema
COVID-19
The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options
Tratamientos
Tema
COVID-19
The convalescent sera option for containing COVID-19
Tratamientos
Tema
COVID-19
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Tratamientos
Tema
COVID-19
Of chloroquine and COVID-19
Tratamientos
Tema
COVID-19
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Tratamientos
Tema
COVID-19
Harnessing the immune system via Fc纬R function in immune therapy A pathway to next- gen mAbs
Tratamientos
Tema
COVID-19
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Tratamientos
Tema
COVID-19
Reducing mortality from 2019-nCoV host-directed therapies should be an option
Tratamientos
Tema
COVID-19
In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus
Tratamientos
Tema
COVID-19
A Trial of Lopinavir鈥揜itonavir in Adults Hospitalized with Severe Covid-19
Tratamientos
Tema
COVID-19
Hydroxychloroquine and azithromycin as a treatment of COVID-19
Tratamientos
Tema
COVID-19
Clinical trials on drug repositioning for COVID-19 treatment
Tratamientos
Tema
COVID-19
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Tratamientos
Tema
COVID-19
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Tratamientos
Tema
COVID-19
Preparing for a COVID19 pandemic
Medidas preventivas
Tema
COVID-19
Taking the right measures to control COVID-19
Medidas preventivas
Tema
COVID-19
«
1
2
3
4
5
6
7
8
9
10
...
21
22
»
Institucional
Misi贸n y Visi贸n de ALAT
Comit茅 Ejecutivo
Estatutos y reglamentos
Actividades de ALAT
Sociedades Nacionales
Miembros
Beneficios
Hacerme miembro
Recursos
Publicaciones
Biblioteca
Cont谩ctenos
Contacto